PHARMASGP HOLDING SE O.N./ DE000A2P4LJ5 /
| 2024-10-25 5:36:08 PM | Chg. -0.400 | Volume | Bid5:36:08 PM | Ask2024-10-25 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 25.600EUR | -1.54% | 156 Turnover: 4,012.400 |
-Bid Size: - | -Ask Size: - | 314.21 mill.EUR | 5.19% | 19.12 |
Assets
|
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
|||||
|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | .4000 | .4000 | .3650 | .3020 | |||||
| Intangible Assets | 1.8000 | 82.2000 | 73.9430 | 66.0560 | |||||
| Long-Term Investments | .0600 | 0.0000 | - | - | |||||
| Fixed Assets | - | - | 77.6000 | 68.4820 | |||||
| Inventories | 3 | 4.2000 | 7.0020 | 10.1170 | |||||
| Accounts Receivable | - | - | 7.7990 | 9.1890 | |||||
| Cash and Cash Equivalents | 8 | 20.8000 | 32.6420 | 40.7660 | |||||
| Current Assets | 22.4000 | 32.5000 | 51.5090 | 62.8170 | |||||
| Total Assets | 24.9000 | 115.3000 | 129.1090 | 131.2990 | |||||
Liabilities
|
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
|||||
|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 9.8000 | 4.5000 | 8.7860 | 9.9200 | |||||
| Long-term debt | - | - | 73.0590 | 65.3700 | |||||
| Liabilities to Banks | 1.2000 | 85.7000 | - | - | |||||
| Provisions | 1 | 1.2000 | 4.4190 | 4.2320 | |||||
| Liabilities | 13.4000 | 93 | 98.0120 | 91.5450 | |||||
| Share Capital | - | - | - | - | |||||
| Total Equity | 11.5070 | 22.1970 | 31.0970 | 39.7540 | |||||
| Minority Interests | - | - | - | - | |||||
| Total liabilities equity | 24.9000 | 115.3000 | 129.1090 | 131.2990 | |||||
Income Statement
|
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
|||||
|---|---|---|---|---|---|---|---|---|---|
| Revenues | 63.2000 | 65.3000 | 85,824 | 101.0990 | |||||
| Depreciation (total) | .5000 | 3.6000 | 9.2500 | 9.3710 | |||||
| Operating Result | 14.2000 | 14.9000 | 17.6830 | 24.6380 | |||||
| Interest Income | -.0900 | -.7000 | -1.8800 | -2.7450 | |||||
| Income Before Taxes | 14.1000 | 14.2000 | - | - | |||||
| Income Taxes | 3.5000 | 3.5000 | 3.8490 | 5.4960 | |||||
| Minority Interests Profit | - | - | 0.0000 | 0.0000 | |||||
| Net Income | 10.6000 | 10.7000 | 11.9540 | 16.3970 | |||||
Per Share
Cash Flow
|
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
|||||
|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 15.5000 | 12.2000 | 24.7130 | 26.6390 | |||||
| Cash Flow from Investing Activities | -.9000 | -83.5000 | -.7870 | -.8660 | |||||
| Cash Flow from Financing | -95 | 84 | -12.1080 | -17.6490 | |||||
| Decrease / Increase in Cash | -80.5000 | 12.8000 | - | - | |||||
| Employees | 60 | 75 | 79 | 89 | |||||
